MoonLake Immunotherapeutics's market cap is currently ―. The company's EPS TTM is $-0.762; its P/E ratio is -57.22; MoonLake Immunotherapeutics is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	$ -2.30M	$ 0.00
Gross Profit	-	-	-	$ -2.30M	-
EBIT	$ -11.59M	$ -12.34M	$ -12.21M	$ -29.62M	$ -14.77M
EBITDA	$ -11.59M	-	$ -12.20M	$ -29.61M	$ -14.77M
Net Income Common Stockholders	$ -9.43M	$ -10.14M	$ -9.00M	$ -25.04M	$ -14.74M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 495.98M	$ 501.79M	$ 63.05M	$ 72.11M	$ 83.46M
Total Assets	$ 500.22M	$ 506.62M	$ 66.75M	$ 76.84M	$ 88.59M
Total Debt	$ 169.42K	$ 211.24K	$ 246.25K	$ 282.58K	$ 0.00
Net Debt	$ -495.81M	$ -501.58M	$ -62.80M	$ -71.83M	$ -83.46M
Total Liabilities	$ 10.58M	$ 7.51M	$ 7.68M	$ 8.08M	$ 6.02M
Stockholders Equity	$ 424.93M	$ 489.80M	$ 42.00M	$ 48.90M	$ 55.29M
Cash Flow	-
Free Cash Flow	$ -9.22M	-	$ -9.01M	$ -11.60M	$ -9.35M
Operating Cash Flow	$ -9.22M	-	$ -9.01M	$ -11.60M	$ -9.35M
Investing Cash Flow	$ -174.38M	-	$ 19.65M	$ 9.90M	$ -42.23M
Financing Cash Flow	-	-	-	$ 3.79K	$ 0.00

Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History

Income Statement >

MoonLake Immunotherapeutics Debt to Assets

Balance Sheet >

MoonLake Immunotherapeutics Cash Flow

Cash Flow >

MoonLake Immunotherapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing